149669-44-3 Usage
Uses
Used in Pharmaceutical Industry:
5-Methyl-3-piperidin-4-yl-1H-indole hydrochloride is used as a potential therapeutic agent for the treatment of neurological disorders. Its structural similarity to serotonin and other neurotransmitters suggests that it may have the capacity to modulate the central nervous system, offering a new avenue for the management of conditions such as depression, anxiety, and other mood disorders.
Used in Drug Development:
In the field of drug development, 5-Methyl-3-piperidin-4-yl-1H-indole hydrochloride is being investigated for its potential as a lead compound. Its unique structure and potential interactions with neurotransmitter systems make it a promising candidate for the creation of new drugs that could address unmet medical needs in the treatment of various neurological and neuropsychiatric conditions.
Used in Medicinal Chemistry:
5-Methyl-3-piperidin-4-yl-1H-indole hydrochloride serves as a valuable compound in medicinal chemistry research. Scientists are studying its chemical properties and interactions with biological targets to understand its potential as a therapeutic agent. This knowledge can be applied to design and synthesize new molecules with improved pharmacological profiles, ultimately leading to the development of more effective treatments for neurological and neuropsychiatric disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 149669-44-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,6,6 and 9 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 149669-44:
(8*1)+(7*4)+(6*9)+(5*6)+(4*6)+(3*9)+(2*4)+(1*4)=183
183 % 10 = 3
So 149669-44-3 is a valid CAS Registry Number.
InChI:InChI=1/C14H18N2.ClH/c1-10-2-3-14-12(8-10)13(9-16-14)11-4-6-15-7-5-11;/h2-3,8-9,11,15-16H,4-7H2,1H3;1H
149669-44-3Relevant academic research and scientific papers
Wei, Jianmei,Pio, Barbara A.,Cai, Hui,Meduna, Steven P.,Sun, Siquan,Gu, Yin,Jiang, Wen,Thurmond, Robin L.,Karlsson, Lars,Edwards, James P.
, p. 5525 - 5528 (2007)
High potency pyrazole-based noncovalent inhibitors of human cathepsin S (CatS) were developed by modification of the benzo-fused 5-membered ring heterocycles found in earlier series of CatS inhibitors. Although substitutions on this heterocyclic framework
